A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck

Author： Hadden J. Verastegui E. Barrera J.L. Kurman M. Meneses A. Zinser J.W. de la Garza J. Hadden E.

Publisher： Elsevier

ISSN： 1567-5769

Source： International Immunopharmacology, Vol.3, Iss.8, 2003-08, pp. : 1073-1081

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Angiogenesis Therapy in Head and Neck Squamous Cell Carcinomas

Current Angiogenesis, Vol. 1, Iss. 1, 2012-04 ,pp. : 26-38

Bentham Science Publishers

Access to resources Recommend Favorite

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck

By Lathers D.M.R. Achille N.J. Young M.R.I.

Human Immunology, Vol. 64, Iss. 12, 2003-12 ,pp. : 1160-1166

Elsevier

Access to resources Recommend Favorite

Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2

By Meneses A. Verastegui E. Barrera J.L. de la Garza J. Hadden J.W.

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1083-1091

Elsevier

Access to resources Recommend Favorite

Molecular-targeted therapy hypoxia in head and neck squamous cell carcinoma patients (Review)

By Adachi Thomas

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 12-14

Spandidos Publications

Access to resources Recommend Favorite

Immunological Approach in the Evaluation of Regional Lymph Nodes of Patients with Squamous Cell Carcinoma of the Head and Neck

By Verastegui E. Morales R. Barrera J.L. Müeller A. Hadden J. Guzman B. Meneses A. Alfaro G.

Clinical Immunology, Vol. 102, Iss. 1, 2002-01 ,pp. : 37-47

Academic Press

Access to resources Recommend Favorite